Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3β
Authors:
- Byung-Hoon LeeBLByung-Hoon Lee
- Sang-Gun AhnSASang-Gun Ahn
- Seon-Hee OhSOSeon-Hee Oh
- 1 February 2012
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 418 (4) , 759-764
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Science and Technology (R13-2003-009)
- National Research Foundation of Korea
This publication has 36 references indexed in Scilit:
- Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG132-treated human pulmonary fibroblast cellsHuman & Experimental Toxicology, 2011
- The Proteasome Inhibitor MG-132 Induces AIF Nuclear Translocation Through Down-Regulation of ERK and Akt/mTOR PathwayNeurochemical Research, 2011
- Survival and death of endoplasmic-reticulum-stressed cells: Role of autophagyWorld Journal of Biological Chemistry, 2011
- The Ubiquitin-Proteasome System as a Prospective Molecular Target for Cancer Treatment and PreventionCurrent Protein & Peptide Science, 2010
- Follicular Thyroid Cancer Cell Growth Inhibition By Proteosome Inhibitor MG132Journal of Surgical Research, 2009
- Proteasome Inhibition Potentiates Antitumor Effects of Photodynamic Therapy in Mice through Induction of Endoplasmic Reticulum Stress and Unfolded Protein ResponseCancer Research, 2009
- The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 statusBlood, 2006
- ERAD: the long road to destructionNature Cell Biology, 2005
- The development of proteasome inhibitors as anticancer drugsCancer Cell, 2004
- Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteinsJournal of Neurochemistry, 2003